Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN121318680A enables high-yield Bexagliflozin intermediate production with reduced costs and supply chain reliability for global buyers.
Patent CN116217633B details chemical synthesis avoiding enzymes. Enables scalable production and cost reduction for nutritional ingredient supply chains.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Novel regioselective protection strategy for >99% pure amino sugar phosphates, offering scalable manufacturing and simplified purification for pharmaceutical intermediates.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Patent CN115677587B enables high-purity antiviral intermediate production. Safe scalable process ensures reliable supply chain and significant cost efficiency.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Novel oxycodone synthesis uses ammonia treatment for copper removal. Enhances purity and scalability for pharmaceutical intermediate supply chains globally.
Novel two-step synthesis of (5-fluoropyrimidin-4-yl) methanol via oxidation and dechlorination. Offers streamlined manufacturing and cost reduction for API intermediates.
Patent CN115594600A reveals a safer, one-step synthesis of chiral (R)-3-aminobutanol using borohydride, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel diazotization method reduces costs for Afoxolaner intermediates. Mild conditions, high yield, scalable production for global supply chains.
Patent CN111205298A details a cost-effective Suzuki coupling route for Forbitasvir RRRS isomers, offering significant advantages in reaction time and purity for pharmaceutical manufacturing.
Patent CN111909067B reveals a novel 5-step total synthesis of D-penicillamine from L-serine, offering high optical purity and scalable production for pharmaceutical supply chains.
Patent CN103193654A reveals a high-yield metalloporphyrin catalytic oxidation process for o-nitrobenzoic acid, offering significant cost reduction and supply chain efficiency for pharmaceutical intermediates.
Patent CN102838533A reveals a novel 2-step synthesis for Roflumilast intermediates, offering improved yields and scalable routes for pharmaceutical manufacturing.
Novel bromine recycling method reduces cost and environmental risk for high-purity pharmaceutical intermediate manufacturing supply chain.
Patent CN105153137A reveals a cost-effective Empagliflozin synthesis route. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Novel non-chromium oxidation method for steroid intermediates. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturing partners globally.